These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 25858021)
21. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213 [TBL] [Abstract][Full Text] [Related]
22. Treatment and Outcome in 65 Children with Optic Pathway Gliomas. El Beltagy MA; Reda M; Enayet A; Zaghloul MS; Awad M; Zekri W; Taha H; El-Khateeb N World Neurosurg; 2016 May; 89():525-34. PubMed ID: 26898488 [TBL] [Abstract][Full Text] [Related]
23. Optic pathway glioma in children: 10 years of experience in a single institution. Doganis D; Pourtsidis A; Tsakiris K; Baka M; Kouri A; Bouhoutsou D; Varvoutsi M; Servitzoglou M; Dana H; Kosmidis H Pediatr Hematol Oncol; 2016 Mar; 33(2):102-8. PubMed ID: 27007263 [TBL] [Abstract][Full Text] [Related]
24. Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: case report and literature review. Mantadakis E; Raissaki M; Danilatou V; Kambourakis A; Stiakaki E; Kalmanti M J Neurooncol; 2004; 67(1-2):95-100. PubMed ID: 15072453 [TBL] [Abstract][Full Text] [Related]
25. Isolated Optic Nerve Glioma in Children With and Without Neurofibromatosis: Retrospective Characterization and Analysis of Outcomes. Hamideh D; Hoehn ME; Harreld JH; Klimo PD; Gajjar A; Qaddoumi I J Child Neurol; 2018 May; 33(6):375-382. PubMed ID: 29502465 [TBL] [Abstract][Full Text] [Related]
27. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma. Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959 [TBL] [Abstract][Full Text] [Related]
28. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review. Cardellicchio S; Bacci G; Farina S; Genitori L; Massimino M; de Martino M; Caputo R; Sardi I Neuropediatrics; 2014 Feb; 45(1):42-9. PubMed ID: 24272769 [TBL] [Abstract][Full Text] [Related]
29. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children. López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Rocha-Moreno YG; Gascón-Lastiri G; Rivera-Márquez H; Wanzke-del-Angel V; Cerecedo-Díaz F; de la Cruz-Yañez H Arch Med Res; 2008 Oct; 39(7):655-62. PubMed ID: 18760193 [TBL] [Abstract][Full Text] [Related]
30. Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey. Azizi AA; Schouten-van Meeteren AYN J Neurooncol; 2018 Jan; 136(1):127-134. PubMed ID: 29071540 [TBL] [Abstract][Full Text] [Related]
31. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1. Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031 [TBL] [Abstract][Full Text] [Related]
33. Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature. Ashur-Fabian O; Blumenthal DT; Bakon M; Nass D; Davis PJ; Hercbergs A Anticancer Drugs; 2013 Mar; 24(3):315-23. PubMed ID: 23348245 [TBL] [Abstract][Full Text] [Related]
34. Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components. Bennebroek CA; Schouten CR; Montauban-van Swijndregt MC; Saeed P; Porro GL; Pott JWR; Dittrich ATM; Oostenbrink R; Schouten-van Meeteren AY; de Jong MC; de Graaf P J Neurooncol; 2024 Jan; 166(1):79-87. PubMed ID: 38150061 [TBL] [Abstract][Full Text] [Related]
35. Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas. Rosca L; Robert-Boire V; Delisle JF; Samson Y; Perreault S Pediatr Blood Cancer; 2018 Nov; 65(11):e27351. PubMed ID: 30014595 [TBL] [Abstract][Full Text] [Related]
36. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases]. Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children. Lafay-Cousin L; Lindzon G; Taylor MD; Hader W; Hawkins C; Nordal R; Laperriere N; Laughlin S; Bouffet E; Bartels U J Neurosurg Pediatr; 2016 Mar; 17(3):298-302. PubMed ID: 26588458 [TBL] [Abstract][Full Text] [Related]
38. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†. Chintagumpala M; Eckel SP; Krailo M; Morris M; Adesina A; Packer R; Lau C; Gajjar A Neuro Oncol; 2015 Aug; 17(8):1132-8. PubMed ID: 25854526 [TBL] [Abstract][Full Text] [Related]